C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioavailable monodac targeting IKZF1 and IKZF...
Leadership
Andrew J. Hirsch M.B.A.
CEO, President & Director
Kenneth C. Anderson M.D., Ph.D.Founder
Co-Founder, Independent Director & Member of Scientific Advisory Board
Kendra R. Adams
Principal Accounting Officer, CFO, Head of Corporate Affairs & Treasurer
Leonard M. J. Reyno M.D.
Chief Medical Officer
Nathanael S. Gray Ph.D.Founder
Co-Founder & Member of Scientific Advisory Board
Paige Mahaney Ph.D.
Chief Scientific Officer
Courtney Solberg
Senior Manager of Investor Relations
Kelly A. Schick
Chief People Officer
Isabel Chiu Ph.D.
Senior Vice President of Strategic Alliances & Business Development
